miRNA-203b-3p Induces Acute and Chronic Pruritus through 5-HTR2B and TRPV4.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
01 2023
Historique:
received: 09 03 2022
revised: 17 06 2022
accepted: 05 08 2022
pubmed: 2 9 2022
medline: 21 12 2022
entrez: 1 9 2022
Statut: ppublish

Résumé

Growing evidence indicates that transient receptor potential (TRP) channels contribute to different forms of pruritus. However, the endogenous mediators that cause itch through transient receptor potential channels signaling are poorly understood. In this study, we show that genetic deletion or pharmacological antagonism of TRPV4 attenuated itch in a mouse model of psoriasis induced by topical application of imiquimod. Human psoriatic lesions showed increased expression of several microRNAs, including the miR-203b-3p, which induced a calcium ion response in rodent dorsal root ganglion neurons and scratching behavior in mice through 5-HTR2B activation and the protein kinase C‒dependent phosphorylation of TRPV4. Computer simulation revealed that the miR-203b-3p core sequence (GUUAAGAA) that causes 5-HTR2B/TRPV4-dependent itch targets the extracellular side of 5-HTR2B by interacting with a portion of the receptor pocket consistent with its activation. Overall, we reveal the unconventional pathophysiological role of an extracellular microRNA that can behave as an itch promoter through 5-HTR2B and TRPV4.

Identifiants

pubmed: 36049541
pii: S0022-202X(22)01883-8
doi: 10.1016/j.jid.2022.08.034
pii:
doi:

Substances chimiques

MicroRNAs 0
TRPV Cation Channels 0
TRPV4 protein, human 0
Trpv4 protein, mouse 0
HTR2B protein, human 0
Receptor, Serotonin, 5-HT2B 0
MIRN203 microRNA, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-153.e10

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Francesco De Logu (F)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Roberto Maglie (R)

Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.

Mustafa Titiz (M)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Giulio Poli (G)

Department of Pharmacy, University of Pisa, Pisa, Italy.

Lorenzo Landini (L)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Matilde Marini (M)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Daniel Souza Monteiro de Araujo (D)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Gaetano De Siena (G)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Marco Montini (M)

Medical Genetics Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.

Daniela Almeida Cabrini (DA)

Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.

Michel Fleith Otuki (MF)

Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.

Priscila Lúcia Pawloski (PL)

Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.

Emiliano Antiga (E)

Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.

Tiziano Tuccinardi (T)

Department of Pharmacy, University of Pisa, Pisa, Italy.

João Batista Calixto (JB)

Centro de Inovação e Ensaios Pré-Clínicos (CIEnP), Florianópolis, Brazil.

Pierangelo Geppetti (P)

Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.

Romina Nassini (R)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy. Electronic address: romina.nassini@unifi.it.

Eunice André (E)

Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH